Engineered microorganisms for the production of intermediates and final products

US11518975B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11518975-B2
Application numberUS-201916399597-A
CountryUS
Kind codeB2
Filing dateApr 30, 2019
Priority dateApr 30, 2018
Publication dateDec 6, 2022
Grant dateDec 6, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to a non-naturally occurring microorganism that includes an endogenous genetic deletion that eliminates the expression of at least a pyruvate kinase, where the genetically modified prokaryotic microorganism is capable of producing 3-deoxy-D-arabino-heptulosonate-7-phosphate.

First claim

Opening claim text (preview).

What is claimed is: 1. A non-naturally occurring Pseudomonas sp. comprising an endogenous genetic deletion that eliminates the expression of a pyruvate kinase encoded by pykF as well as genetic deletions of gcd and hexR genes, wherein the microorganism is capable of producing 3-deoxy-D-arabino-heptulosonate-7-phosphate and muconic acid; and wherein the muconic acid production is greater than that in the naturally occurring Pseudomonas sp. 2. The microorganism of claim 1 , wherein the microorganism is selected from the group consisting of P. putida, P. fluorescens , and P. stutzeri. 3. The microorganism of claim 2 , wherein the microorganism is P. putida KT2440. 4. The microorganism of claim 1 , wherein the microorganism catabolizes at least one of a lignin depolymerization product, a cellulose depolymerization product, and a hemicellulose depolymerization product. 5. The microorganism of claim 4 , wherein the lignin depolymerization product comprises an aromatic compound. 6. The microorganism of claim 4 , wherein the cellulose depolymerization product comprises glucose.

Assignees

Inventors

Classifications

  • Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases · CPC title

  • acting on CH-OH groups as donors (1.1) · CPC title

  • C12N1/20Primary

    Bacteria; Culture media therefor · CPC title

  • C12N9/1085Primary

    transferring alkyl or aryl groups other than methyl groups (2.5) · CPC title

  • Lyases (4.) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11518975B2 cover?
The present disclosure relates to a non-naturally occurring microorganism that includes an endogenous genetic deletion that eliminates the expression of at least a pyruvate kinase, where the genetically modified prokaryotic microorganism is capable of producing 3-deoxy-D-arabino-heptulosonate-7-phosphate.
Who is the assignee on this patent?
Alliance Sustainable Energy, Ut Battelle Llc, Triad Nat Security Llc
What technology area does this patent fall under?
Primary CPC classification C12N1/20. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).